CN118178328A — 依达拉奉包埋物制备方法与其口服制剂
Assigned to Yaoyun Xi'an Pharmaceutical Technology Co ltd · Expires 2024-06-14 · 2y expired
What this patent protects
本发明公开了一种依达拉奉包埋物制备方法与其口服制剂。本发明优选给出了三种依达拉奉包埋物制备方法,经包埋后的依达拉奉未检测出针状结晶,确保了依达拉奉的稳定性,降低了依达拉奉制剂制备时发生结晶的概率,减少依达拉奉制剂中聚合物杂质的产生。采用依达拉奉包埋物制备口崩片或口溶膜,提高了依达拉奉的体外溶出速率和生物利用度。本发明有效解决了依达拉奉现有制剂的诸多技术问题,方便给药,为依达拉奉口服制剂的开发提供了技术支撑。
USPTO Abstract
本发明公开了一种依达拉奉包埋物制备方法与其口服制剂。本发明优选给出了三种依达拉奉包埋物制备方法,经包埋后的依达拉奉未检测出针状结晶,确保了依达拉奉的稳定性,降低了依达拉奉制剂制备时发生结晶的概率,减少依达拉奉制剂中聚合物杂质的产生。采用依达拉奉包埋物制备口崩片或口溶膜,提高了依达拉奉的体外溶出速率和生物利用度。本发明有效解决了依达拉奉现有制剂的诸多技术问题,方便给药,为依达拉奉口服制剂的开发提供了技术支撑。
Drugs covered by this patent
- Radicava (EDARAVONE) · Kk Bcj-94
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.